Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹1,439.40
1.90 (0.13%)
Medium VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹1.16L Cr
LARGE CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
30.1
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹1,165.7+23.5%
52W High₹1,673-14.0%
Current Price
₹1,439.40
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹1,151.52
Upper Circuit₹1,727.28
Reference Price
₹1,439.40
Investment Checklist
Head and Shoulders on 1W (BREAKOUT CONFIRMED) — target ₹1297.6
Triple Top on 1D (BREAKOUT CONFIRMED) — target ₹1348.8
Trend: Price above all key MAs — strong uptrend
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
SuperTrend(7,3): Price above SuperTrend (Responsive Setting (Day Trading/Short-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
76%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend
EMA20
1429.41
EMA50
1393.71
EMA200
1416.4
Price Action
CONSOLIDATION
NEUTRAL
Higher Highs3
Higher Lows4
Lower Highs6
Lower Lows5
Support & Resistance Levels
Resistance (Above)
₹1470.42
₹1534.00
₹1592.90
₹1673.00
Support (Below)
₹1381.30
₹1351.94
₹1312.30
₹1283.03
₹1257.00
Volume Analysis
TrendDECREASING
Change-24.40%
Unusual VolumeNo
Stop Loss Levels
Fixed Risk
1% Risk₹1425.01
3% Risk₹1396.22
5% Risk₹1367.43
7% Risk (Custom)
₹1338.64Technical Levels
1x ATR (Volatility)₹1410.59
2x ATR (Swing)₹1381.78
3x ATR (Trend)₹1352.97
Immediate Support₹1381.30
Moving Averages
EMA 20 (Medium-term)₹1429.41
EMA 50 (Trend)₹1393.71
EMA 200 (Long-term)₹1416.40
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹6,961.6 Cr | ₹6,597.7 Cr | ₹6,837 Cr | ₹6,963 Cr |
| Net Profit | ₹1,570.5 Cr | ₹1,221.8 Cr | ₹1,297.6 Cr | ₹675.8 Cr |
| EPS | ₹19.45 | — | ₹16.07 | ₹8.37 |
| Operating Profit | ₹2,210.5 Cr | ₹1,697.6 Cr | ₹2,036.7 Cr | ₹1,185.5 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Biocon Limited | ₹418.50 | +3.70% | 177.4 | ₹67.83K Cr mid Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 05 Jun 2026 | Dividend - Rs 13 Per Share | DIVIDEND |
| 27 Jun 2025 | Dividend - Rs 13 Per Share/Special Dividend - Rs 3 Per Share | SPECIAL_DIVIDEND |
| 02 Aug 2024 | Dividend - Rs 13 Per Share | DIVIDEND |
| 21 Jul 2023 | Dividend - Rs 8.50 Per Share | DIVIDEND |
| 08 Aug 2022 | Dividend - Rs 5 Per Share | DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
| Date | Purpose | Type |
|---|---|---|
| 23 Jul 2026 | Financial Results | RESULTS |
Latest News
News for CIPLA
View All
positive
ET Markets - Stocks 1d ago
Cipla Share Price Live Updates: Cipla's Weekly Trading Metrics
CIPLAHealthcare
positive
CNBC TV18 - Markets 2d ago
Explained - Why Jefferies is bearish on Dr. Reddy's and Cipla but bullish on Mankind Pharma
Jefferies has mixed views on pharma stocks. It has an "underperform" rating on Dr Reddy's and Cipla, and a "buy" recommendation on Mankind Pharma.
CIPLAMANKINDHealthcare
positive